Uncategorized

Novo Nordisk shares plunge 19% after disappointing trial results; Lilly jumps in premarket – CNBC

Posted on Author Comments Off on Novo Nordisk shares plunge 19% after disappointing trial results; Lilly jumps in premarket – CNBC
  1. Novo Nordisk shares plunge 19% after disappointing trial results; Lilly jumps in premarket  CNBC
  2. Novo Nordisk Shares Plunge After New Obesity Shot Falls Short of Expectations  The Wall Street Journal
  3. Novo Nordisk’s next-generation weight-loss drug matches Lilly’s Zepbound in major trial, but doesn’t surpass it  CNN
  4. Novo Nordisk Stock Crashes 22% After Disappointing Obesity Drug Data. Eli Lilly Shares Soar.  Barron’s
  5. Danish Krone Slips After Novo Tanks on Disappointing Drug Data  Bloomberg